DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics. This product is the plasmid containing an encoded mouse anti-PMEL DMAb (Clone SPM286) sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-WFY5824||Anti-PMEL (CBFYM-3062) h(CD28-CD3ζ) CAR, pCDCAR1|
|TCR-C076Z||Human anti-gp100 T cell receptor (gp100), pCDTCR1|
|CAR-LY632||Anti-PMEL (SPM286) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-WFY1717||Anti-PMEL (CBFYH-3632) h(41BB-CD3ζ) CAR, pCDCAR1|
|TCR-L374||Mouse anti-gp100 T cell receptor (T2(1)P), pCDTCR1|
|VP-TCR-C401||Lenti-gp100 T cell receptor (T2(1)G) Viral Particle|
|TCR-C083Z||Human anti-gp100 T cell receptor (L2G2), pCDTCR1|
|VP-TCR-C416||Lenti-gp100 T cell receptor (Sp(1)B) Viral Particle|
|VP-TCR-C402||Lenti-gp100 T cell receptor (T2(1)M) Viral Particle|
|VP-TCR-C388||Lenti-gp100 T cell receptor (T2(1)C) Viral Particle|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved